Radiofrequency Ablation of Ectopic Atrial Tachycardia

Status Terminated

Clinical Trial Summary

A retrospective chart review will be performed on 50 patients who received RFA for the treatment of EAT between August 1992 and August 2003 at Children's Healthcare of Atlanta.

The use of the CARTO/Biosense catheter has improved outcomes with decreased radiation exposure to patients.

Clinical Trial Description

Ectopic Atrial Tachycardia (EAT) is a relatively rare arrhythmia in the pediatric population. It is defined by a run of more than 3 premature atrial contractions together. In EAT, the arrhythmia tends to increase in rate over a period of time and then slows down gradually to a normal rhythm. Ectopic Atrial Tachycardia (EAT) is mostly encountered in patients with structurally normal hearts however, occasionally physicians do observe this type of disorder in children following surgery for congenital heart defects. Current reports suggest that EAT occurs in approximately 1 in 10,000 children (Hamilton, 2002).

Children with EAT usually present with a multitude of symptoms. The most common symptoms associated with pediatric EAT are palpitations, chest pain, lightheadedness, presyncope, and dyspnea. Other symptoms can include exercise intolerance and congestive heart failure. These are usually late manifestations. In the patients with tachycardia induced CM, the time of development of CM is dependent on the rate and duration of the tachycardia however, in most cases, dilation is present upon diagnosis. This CM can be reversed with successful treatment of the arrhythmia.

The treatment for chronic EAT includes medications such as adenosine and for difficult to control cases, Radiofrequency Ablation (RFA). RF ablation has been successful in curing EAT, with success rates ranging from 75-100%. It has been shown that the complication rates are similar to other RF ablation procedures, with a higher risk of recurrence (Hamilton, 2002).

At Children's Healthcare of Atlanta, the cardiac catheterization lab performs approximately 10 Radiofrequency ablations for EAT each year. The goal of this retrospective review is to assess the frequency of recurrence of the EAT among a subset of patients receiving treatment between August 1992 - August 2003 ;

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00267982
Study type	Observational
Source	Children's Healthcare of Atlanta
Contact
Status	Terminated
Phase	N/A
Start date	August 1992
Completion date	February 2008

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04405700` - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Not yet recruiting	`NCT03291678` - Impact of Percutaneous Laparoscopic Assisted Internal Ring Ligation During Lap Orchiopexy	N/A
Completed	`NCT00489788` - Predictors for Pulmonary Valve Replacement - Anatomic and Hemodynamic Using MRI	N/A
Terminated	`NCT00268060` - Infant Medical Records: Case Report Proposal	N/A
Not yet recruiting	`NCT05955794` - Vocal Pattern Assessment as a New Key to Identifying Rare Syndromes	N/A
Completed	`NCT00257517` - Multisite Feeding Study: Home Surveillance and Feeding Strategies in Infants With Complex Single Ventricle	N/A
Completed	`NCT00478296` - Pulmonary Hypertension in Trisomy 21 Patients	N/A
Completed	`NCT04556487` - Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)
Terminated	`NCT00261989` - Pulse Oximetry Readings and Hourly Variation in Oximetry Readings With CHD	N/A
Completed	`NCT00211081` - Spironolactone in Patients With Single Ventricle Heart	N/A
Terminated	`NCT00268099` - Optimal Timing for Repair of Right-to-Left Shunt Lesions	N/A
Active, not recruiting	`NCT05752019` - TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
Completed	`NCT00490295` - Biomarkers for Detection of Brain Ischemia	N/A
Terminated	`NCT00327899` - Home Inotropic Therapy in Children	N/A
Terminated	`NCT00229905` - Child With Anomalous Drainage of IVC to Left Atrium	N/A
Completed	`NCT00277901` - MRI Assessment of RV Function: Patients With TOF or Aortic Coarctation	N/A
Terminated	`NCT00366314` - Frequency of Accessing Central Lines for Blood Samples	N/A
Terminated	`NCT00268034` - Left Ventricular Aneurysms in Children	N/A
Completed	`NCT00366847` - Computer Modeling of Congenital Heart Disease	N/A
Withdrawn	`NCT00460824` - A Retrospective Review - Anti-HLA Antibodies	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.